Navam Capital

Navam Capital is an India-based venture capital firm established in 2008 and based in Kolkata. It focuses on seed and early-stage investments across technology, energy, health care, and science-related sectors.

Rajeev Mantri

Founder and Managing Director

Tarun Mehta

Venture Partner

Shiladitya Sengupta Ph.D

Venture Partner

19 past transactions

Vayudh

Venture Round in 2025
Vayudh's aim is to create next-generation nanodrones and swarming technologies for modern defense and security applications.

GalaxEye

Series A in 2024
GalaxEye offers satellite-based imaging services, providing high-frequency Earth observation data. It specializes in multi-sensor imaging satellites with superior spatial and temporal resolution, empowering businesses across government and commercial sectors to make informed decisions and enhance operational efficiency through space technology.

Alyssum Therapeutics

Series A in 2024
Alyssum Therapeutics is a biotechnology company specializing in the development of next-generation immunotherapies focused on modulating B cells.

Aereo

Series B in 2024
Aereo is a Bangalore-based Indian drone manufacturer and solutions provider focused on end-to-end enterprise drone technology for industries including urban and rural development, agriculture, mining, construction, irrigation, forest conservation, renewable energy, and infrastructure. Founded in 2013 as Aarav Unmanned Systems at IIT Kanpur, it offers survey-grade drones with secure three-dimensional web-GIS and 360-degree visibility, enabling users to process over fifty thousand images per instance with multi-stage quality checks. The company has introduced India’s first DGCA-certified survey-grade PPK drone and has mapped over 34,000 villages, touching the lives of more than 45 million people through aerial intelligence that supports critical decision-making and productivity.

Morphing Machines

Seed Round in 2024
Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have been developed at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas. REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings.

TechEagle

Convertible Note in 2024
TechEagle is a drone logistics company focused on ultrafast, temperature-controlled last-mile delivery for healthcare, e-commerce and essential goods. It develops long-range, heavy-payload drones and autonomous fleet management systems, backed by cloud-based software and UTM traffic management to coordinate operations. The company serves multiple sectors including healthcare, e-commerce, maritime, hyperlocal and government, and has executed projects with organizations such as AIIMS and India Post. Based in India, TechEagle holds regulatory approvals for operations in restricted airspace, underscoring its commitment to safe, reliable deliveries of medicines, vaccines and perishables. Its technology enables doorstep package delivery through a global drone delivery network, positioning TechEagle as a leader in drone-enabled logistics.

Fasal

Series A in 2023
Fasal, developed by Wolkus Technology Solutions, is an agri-tech platform that leverages artificial intelligence to enhance the agricultural ecosystem. It records various growing conditions on farms and employs data science to make accurate predictions regarding on-farm practices. The platform delivers insights across multiple devices, including iOS, Android, tablets, and web interfaces, ensuring accessibility for users. Fasal's precision agriculture solutions provide real-time agronomic recommendations based on data collected from agnostic sensors, which monitor on-farm and micro-climate conditions. By offering detailed, crop-specific intelligence—including predictive weather information and pest management strategies—Fasal helps farmers optimize their resources, resulting in significant cost savings on water, energy, fertilizers, and pesticides while increasing overall harvest yields.

Ather Energy

Series E in 2022
Ather Energy specializes in manufacturing electric scooters and developing an extensive charging network called AtherGrid. The company focuses on creating a comprehensive ecosystem for India's electric vehicles, with all products designed and manufactured locally.

Tvasta

Seed Round in 2021
Tvasta is a company focused on advancing manufacturing and automation technologies, with a particular emphasis on 3D printing. It aims to revolutionize product development and delivery across various sectors, including construction, automotive, aerospace, and medical industries. Tvasta designs innovative 3D printers capable of working with diverse materials such as concrete, metals, polymers, and ceramics. By prioritizing research and development, Tvasta seeks to enhance human productivity and enable deep personalization in its offerings, ultimately providing an integrated end-to-end experience for its customers.

Alyssum Therapeutics

Seed Round in 2020
Alyssum Therapeutics is a biotechnology company specializing in the development of next-generation immunotherapies focused on modulating B cells.

Agnikul

Seed Round in 2019
Agnikul Cosmos Private Limited is an Indian space technology startup founded in 2017 and based in Chennai, Tamil Nadu. The company specializes in the design, manufacture, testing, and launch of orbital-class rockets specifically tailored for micro and nanosatellites. Operating from the National Center for Combustion R&D at IIT-Madras, Agnikul's team comprises rocket scientists, engineers, ex-bankers, and space lawyers, contributing to a diverse skill set that enhances its capabilities. The company's launch vehicles are fully mobile and can be deployed from various launch ports, utilizing kerosene as fuel. This innovative approach allows for access to both low and high-inclination orbits, providing customers with on-demand access to space at competitive prices.

Orangewood Labs

Seed Round in 2018
Orangewood Labs Inc. is a San Francisco-based company that specializes in manufacturing and distributing customized furniture. In addition to its furniture operations, the company is developing robotic arms designed specifically for small businesses. These robots are intended to democratize access to automation in manufacturing, offering solutions that are safe, user-friendly, and affordable. Through its innovative approach, Orangewood Labs aims to address contemporary manufacturing challenges, making advanced robotic technology accessible to a wider range of enterprises.

Invictus Oncology

Series A in 2016
Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics

Series B in 2014
Vyome Therapeutics develops innovative drugs targeting antibiotic-resistant acne and other pathogens, focusing on preventing resistance development. Its product pipeline includes VB 1953 for drug-resistant acne, along with anti-dandruff products like VB 001, VB 2421, VB 3222, and VB 7731. Vyome operates state-of-the-art facilities for research, development, formulation, analytics, biology, clinical trials, and regulatory processes.

Invictus Oncology

Series A in 2013
Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics

Series A in 2012
Vyome Therapeutics develops innovative drugs targeting antibiotic-resistant acne and other pathogens, focusing on preventing resistance development. Its product pipeline includes VB 1953 for drug-resistant acne, along with anti-dandruff products like VB 001, VB 2421, VB 3222, and VB 7731. Vyome operates state-of-the-art facilities for research, development, formulation, analytics, biology, clinical trials, and regulatory processes.

Vyome Therapeutics

Seed Round in 2010
Vyome Therapeutics develops innovative drugs targeting antibiotic-resistant acne and other pathogens, focusing on preventing resistance development. Its product pipeline includes VB 1953 for drug-resistant acne, along with anti-dandruff products like VB 001, VB 2421, VB 3222, and VB 7731. Vyome operates state-of-the-art facilities for research, development, formulation, analytics, biology, clinical trials, and regulatory processes.

EnNatura Technology Ventures

Seed Round in 2010
EnNatura Technology Ventures (P) Ltd. is a clean materials company based in New Delhi, India, founded in 2006. The company focuses on developing specialty chemicals derived from renewable sources, emphasizing sustainability in its product offerings. EnNatura designs innovative polymers that aim to reduce hydrocarbon consumption, contributing to environmental conservation. Additionally, the company provides a resin platform tailored for applications in the printing ink industry, along with producing eco-friendly printing inks. Through its commitment to clean technology, EnNatura Technology Ventures strives to address the challenges of conventional materials and promote greener alternatives in various industrial sectors.

Frinks AI

Frinks AI is an AI Software Development firm offering Effective, Efficient and Reliable Quality Control.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.